Literature DB >> 7754829

Microsurgery of the cervical spine in elderly patients. Part 2: Surgery of malignant tumourous disease.

V Seifert1, F M van Krieken, S D Bao, D Stolke, M Zimmermann.   

Abstract

In this retrospective study, the results of surgery were examined in 25 patients, 65 years of age or older, suffering from malignant tumour growth along the cervical spine. The group consisted of 17 men and 8 women. The mean age was 73 years, ranging from 66 to 88 years. The pathology identified was metastasis in 23 patients, and plasmocytoma in two. The tumour localization involved a single segment of the cervical spine in 12 patients, two segments in 8 patients, three segments in 4 patients, and four segments in one patient. Pre-operatively, 8 patients (32%) suffered solely from severe pain. 6 patients (24%) showed severe pain and radicular nerve compression. 5 patients (20%) had incomplete para- or tetraparesis but were able to walk, and again 6 patients (24%) had incomplete para- or tetraparesis, and were unable to walk. A multitude of accompanying systemic diseases was present in the majority of patients. Evaluation of the peri-operative risk profile was performed using the American Society of Anaesthesiology (ASA) Grading of Physical Status Score. Operation consisted of microsurgical tumour removal, usually incorporating a single- or multi-level vertebrectomy, with radical epidural decompression, and grafting with bone cement followed by an appropriate osteosynthesis. Of the whole cohort of patients treated, four patients were still alive at the time of the last follow-up evaluation. 21 patients died. Four patients died within seven days after surgery. The remaining 17 patients died during the follow-up period. All of these patients died from systemic spread of their primary cancer.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 7754829     DOI: 10.1007/BF01808621

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  17 in total

Review 1.  Innovative cervical fusion and instrumentation techniques.

Authors:  V K Sonntag; I Kalfas
Journal:  Clin Neurosurg       Date:  1991

2.  Metastatic lesions of the upper cervical spine.

Authors:  E Phillips; A M Levine
Journal:  Spine (Phila Pa 1976)       Date:  1989-10       Impact factor: 3.468

3.  Computer analysis of postanesthetic deaths.

Authors:  G F Marx; C V Mateo; L R Orkin
Journal:  Anesthesiology       Date:  1973-07       Impact factor: 7.892

4.  Anterior plate fixation in spine tumor surgery. Indications, technique, and results.

Authors:  D J Hall; J K Webb
Journal:  Spine (Phila Pa 1976)       Date:  1991-03       Impact factor: 3.468

5.  The use of methylmethacrylate for vertebral-body replacement and anterior stabilization of pathological fracture-dislocations of the spine due to metastatic malignant disease.

Authors:  K D Harrington
Journal:  J Bone Joint Surg Am       Date:  1981-01       Impact factor: 5.284

6.  Epidural spinal cord compression from metastatic tumor: diagnosis and treatment.

Authors:  R W Gilbert; J H Kim; J B Posner
Journal:  Ann Neurol       Date:  1978-01       Impact factor: 10.422

7.  Vertebral body resection in the treatment of cancer involving the spine.

Authors:  N Sundaresan; J H Galicich; M S Bains; N Martini; E J Beattie
Journal:  Cancer       Date:  1984-03-15       Impact factor: 6.860

8.  Pathologic vertebral compression in spinal malignancy secondary to intervertebral disk expansion.

Authors:  M J White; J R Jinkins
Journal:  Comput Med Imaging Graph       Date:  1991 Sep-Oct       Impact factor: 4.790

9.  Multisegmental cervical spondylosis: treatment by spondylectomy, microsurgical decompression, and osteosynthesis.

Authors:  V Seifert; D Stolke
Journal:  Neurosurgery       Date:  1991-10       Impact factor: 4.654

10.  Spinal epidural neoplasia. A 15-year review of the results of surgical therapy.

Authors:  R C Dunn; W A Kelly; R N Wohns; J F Howe
Journal:  J Neurosurg       Date:  1980-01       Impact factor: 5.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.